Blue Horizon International careers

Stem cell therapy has successfully proven to regenerate the human body without the need for medicine or surgery. Patients suffering from chronic, often debilitating diseases can benefit from the regenerative properties of this emerging therapy.
The use of stem cells to treat a variety of diseases and conditions is increasing rapidly and includes the treatment of diabetes to cancer to COVID-19 to neurological conditions.
In recent years, Mesenchymal Stem Cells derived from Wharton’s Jelly in human umbilical cords have become the gold standard for stem cell therapy.
At Blue Horizon, our Wharton's Jelly MSCs are quality assured, ethically derived, and versatile and potent. Our cells exhibit remarkable immune and anti-inflammatory, which avoids Graft v Host disease and other potential challenges that may come from using a donor’s stem cells.
Since these cells can differentiate and produce a wide variety of important proteins and growth factors, MSCs can be used to induce a patient’s own body to regenerate tissue.
There is currently promising research using MSCs for degenerative conditions such as Alzheimer’s, ALS, and Parkinson’s; autoimmune diseases including rheumatoid arthritis, lupus, MS, and diabetes; and vascular conditions like stroke and heart disease.
We are led by an accomplished scientific and medical team that draws on its relationships with international partners who have successfully treated thousands of patients with stem cell therapy.